Quarterly snapshots from biopharma companies with marketed products, including: Vertex.

The latest global regulatory news, changes and updates affecting biopharma, including: Researcher gets prison time for trade secret theft; USPTO responds to COVID-19 challenge.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Bayer, BMS, Cerecor, Chinook, Durect, Kintor, Mustang, Neurmedix, Paxmedica, Russian Direct Investment Fund, Sesen, SQZ, VBI Vaccines.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adagene, Adamas, Adverum, Aeterna, Aikido, Annovis, Ascentage, Bharat Biotech, Biovaxys, Can-Fite, Cevec, Circ, Coherus, Engrail, Evozyne, Exelixis, Genentech, Harbour Biomed, Ilias, Immunome, Junshi, Maia, Mati, Max, Moleculin, Neurocycle, Novelion, Ocugen, Ono, Oragenics, Paragon, Probiogen, Q, Regeneron, Ribon, Rznomics, Viewpoint Molecular, Virios, X-Chem, Zebiai, Zydus.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abpro, Arch, Arena, Biomx, BMS, Bridgebio, Calcimedica, Cassava, Chemomab, Curis, Daiichi, Diurnal, Exonate, Gedea, Gemini, Immunovant, Janssen, Kira, Pharnext, Pinteon, RDIF, Secura, Selva, Tiziana, Travere, Verona.

Biopharmas raising money in public or private financings, including: Arcutis, Argenx, Biovaxys, Curevac, Enalare, Eyepoint, Pluristem, Revelation, Revolution.

New hires and promotions in the biopharma industry, including: Actimed, Allena, Biofrontera, Destiny, Elicio, Gain, Imago, Lipum, Oncosec, Quralis, Sangamo, Scenic, Tryp, Windtree.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Arcus, Aicuris, Algernon, Akari, Biontech, Cognition, Curevac, Dynavax, Eversana, Gilead, Gritstone, Iterum, Kamada, Metrion, Noveome, Nyrada, Pfizer, Rentschler, Sonnet, Sosei, Sumitomo Dainippon, Titan, Valneva, Vir.